TSH Biopharm Co Ltd 2025 Sustainability Report
Company: TSH Biopharm Co Ltd
Sector: Wholesale & retail
Country: Taiwan
Year: 2025
Type: Sustainability Report
Pages: 200
The report highlights TSH Biopharm's 2025 liquid-biopsy advances and its 85.3% gene-mutation detection rate, alongside a record consolidated revenue of NT$1,336,523 thousand. It also describes the Leopard Cat Rice Watershed Restoration Project, reporting 2025 monitoring across 195 species and actions to reduce chemical inputs and support local habitat. The report presents these initiatives as part of its broader work on patient access, environmental sustainability, and community care.
Services
From bulk PDFs to structured indicators and machine-readable documents.